QA: AKORN INC in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000003116_2019_AKORN_INC.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0000003116')"}

Graph

Absolute values for 0000003116, AKORN INC

  xvar xval
0 AssetsCurrent 583,819,000
1 IntangibleAssetsNetIncludingGoodwill 568,855,000
2 PropertyPlantAndEquipmentNet 334,853,000
3 remainder_Assets 7,730,000
4 LiabilitiesCurrent 170,823,000
5 LiabilitiesNoncurrent 880,568,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 448,002,000
8 SellingGeneralAndAdministrativeExpense 279,628,000
9 ResearchAndDevelopmentExpense 47,321,000
10 remainder_Expenses 276,436,000
11 remainder_Revenues 694,018,000
12 remainder_NetIncome -44,540,000
13 remainder_ComprehensiveNetIncome -9,551,000
  yvar yval
0 Assets 1,495,257,000
1 Liabilities 1,051,391,000
2 Expenses 1,051,387,000
3 Revenues 694,018,000
4 StockholdersEquity 443,866,000
5 NetIncome -401,909,000
6 ComprehensiveNetIncome -406,684,500
7 BaseVar 2,173,072,000
8 EconomicCapitalRatio 0.280

Edgar->Model Mapping

Feature Distribution

Change over Time